Second generation liquid platelet concentrates: A literature review

(E-pub Abstract Ahead of Print)

Author(s): Rucha Shah*, Triveni M. Gowda, Raison Thomas, Tarun Kumar

Journal Name: Current Pharmaceutical Biotechnology


Become EABM
Become Reviewer
Call for Editor

Abstract:

Liquid or injectable platelet rich fibrin (PRF) is a second-generation platelet concentrate which is completely autologous and free of external additives like bovine thrombin and calcium chloride. Additionally, it is the only one to be obtained in a liquid form among the second generation platelet concentrates. This allows for wide applications such as to maximize injections or mixing with biomaterials such as bone grafts or antibiotics. Since it was first introduced in 2015, several modifications of the original protocol have been proposed which aim at maximizing its biological and mechanical properties. This includes changes in centrifugation speed, time, and so on. The aim of this review is to summarize the various modifications of the injectable/liquid formation of PRF as well as to discuss the potential applications and future research direction.

Keywords: Blood platelets, fibrin, growth factors, leukocytes, injectable platelet-rich fibrin, platelet concentrate

Rights & PermissionsPrintExport Cite as

Article Details

Published on: 22 August, 2021
(E-pub Abstract Ahead of Print)
DOI: 10.2174/1389201022666210823102618
Price: $95